Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
Experimental combo for Graft-Versus-Host disease fails to enroll
Disease control TerminatedThis study tested a mix of drugs (cyclophosphamide, sirolimus, low-dose IL-2, and azacitidine) to treat severe graft-versus-host disease that didn't respond to steroids. Only 3 patients were enrolled before the trial was stopped early. The goal was to see if the treatment could c…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 23, 2026 19:18 UTC
-
Blood cancer transplant study halted early: which prep works best?
Disease control TerminatedThis study tested two different drug combinations given before a stem cell transplant for people with certain blood cancers (like leukemia). The goal was to see which combination better prevented the cancer from coming back within a year. The study was stopped early after enrolli…
Phase: PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
Blood pressure drug tested to stop transplant complication
Disease control TerminatedThis study tested whether the blood pressure drug telmisartan could prevent acute graft-versus-host disease (GVHD) in 32 people with blood cancers receiving a stem cell transplant. GVHD is a serious complication where donor cells attack the patient's body. The trial was stopped e…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Immunotherapy combo after transplant shows promise for High-Risk blood cancers
Disease control TerminatedThis study tested whether giving two immunotherapy drugs (nivolumab and ipilimumab) after a stem cell transplant could safely help control high-risk multiple myeloma and lymphoma. It involved 46 adults aged 18-80 whose cancer was at high risk of coming back. The main goal was to …
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Stem cell study for older myeloma patients halted early
Disease control TerminatedThis study looked at two different high-dose chemotherapy treatments for people aged 65 and older with multiple myeloma, a type of blood cancer. Participants received either the standard chemotherapy (melphalan) or a combination of melphalan and another drug (bortezomib) before a…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Can a simple pill duo make medical abortion more comfortable?
Symptom relief TerminatedThis early-stage trial tested whether taking ibuprofen (a pain reliever) and ondansetron (an anti-nausea drug) before a medical abortion could reduce side effects and improve patient satisfaction. The study enrolled 8 healthy women undergoing early medical abortion (up to 70 days…
Phase: EARLY_PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 18, 2026 11:48 UTC
-
Can a culturally tailored program help hispanic men better manage diabetes?
Symptom relief TerminatedThis study looked at whether a diabetes education program designed specifically for adult Hispanic men (ages 18-64) with type 2 diabetes could improve their self-care habits, such as healthy eating, physical activity, and taking medication as prescribed. The program was offered i…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 16, 2026 12:48 UTC
-
Antibiotic resistance explored in myeloma stem cell transplants
Knowledge-focused TerminatedThis study aimed to find out how common antibiotic resistance is in multiple myeloma patients receiving a stem cell transplant. Researchers planned to collect data from 124 adults to help design future studies on preventing infections. The study was stopped early, so results are …
Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:03 UTC
-
Tablet teaching for diabetes: a new way to learn?
Knowledge-focused TerminatedThis study looked at whether using a bedside tablet with educational modules helps people newly diagnosed with type 1 diabetes learn more about their condition compared to standard paper-based education. About 28 participants were enrolled. The study was ended early, so results a…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC